<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35552722</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>02</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Estimating the Burden of Influenza-like Illness on Daily Activity at the Population Scale Using Commercial Wearable Sensors.</ArticleTitle><Pagination><StartPage>e2211958</StartPage><MedlinePgn>e2211958</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2211958</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2022.11958</ELocationID><Abstract><AbstractText Label="IMPORTANCE">The severity of viral infections can vary widely, from asymptomatic cases to complications leading to hospitalizations and death. Milder cases, despite being more prevalent, often go undocumented, and their public health burden is not accurately estimated.</AbstractText><AbstractText Label="OBJECTIVE">To estimate the true burden of influenza-like illness (ILI) in the US population using a surrogate measure of daily steps lost as measured by commercial wearable sensors.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This cohort study modeled data from 15&#x202f;122 US adults who reported ILI symptoms during the 2018-2019 influenza season (before the COVID-19 pandemic) and who had a sufficient density of wearable sensor data at symptom onset. Participants' minute-level step data as measured by commercial wearable sensors were collected from October 1, 2018, through June 30, 2019. Minute-level activity time series were transformed into day-level time series per user, indicating the total number of steps daily.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary end point was the number of steps lost during the period of 4 days before symptom onset (the latent phase) through 11 days after symptom onset (the symptomatic phase). The association between covariates and steps lost during this interval was also examined.</AbstractText><AbstractText Label="RESULTS">Of the 15&#x202f;122 participants in this study, 13&#x202f;108 (86.7%) were women, and the median age was 32 years (IQR, 27-38 years). For their ILI event, 2836 of 15&#x202f;080 participants (18.8%) sought medical attention, and only 61 (0.4%) were hospitalized. Over the course of an ILI lasting 10 days, the mean cumulative loss was 4437 steps (95% CI, 4143-4731 steps). After weighting, there was an estimated overall nationwide reduction in mobility equivalent to 255.2 billion steps (95% CI, 232.9-277.6 billion steps) lost because of ILI symptoms during the study period. This finding reflects significant changes in routines, mobility, and employment and is equivalent to 15% of the active US population becoming completely immobilized for 1 day. Moreover, 60.6% of this reduction in steps (154.6 billion steps [95% CI, 138.1-171.2 billion steps]) occurred among persons who sought no medical care. Age and educational level were positively associated with steps lost.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">These findings suggest that most of the burden of ILI in this study would have been invisible to health care and public health reporting systems. This approach has applications for public health, health care, and clinical research, from estimating costs of lost productivity at population scale, to measuring effectiveness of anti-ILI treatments, to monitoring recovery after acute viral syndromes such as during long COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mezlini</LastName><ForeName>Aziz</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Evidation Health Inc, Menlo Park, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapiro</LastName><ForeName>Allison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Evidation Health Inc, Menlo Park, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daza</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Evidation Health Inc, Menlo Park, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caddigan</LastName><ForeName>Eamon</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Evidation Health Inc, Menlo Park, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Ernesto</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Evidation Health Inc, Menlo Park, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Althoff</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Paul G. Allen School of Computer Science &amp; Engineering, University of Washington, Seattle.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foschini</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Evidation Health Inc, Menlo Park, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076251" MajorTopicYN="Y">Wearable Electronic Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Drs Mezlini, Shapiro, Daza, Caddigan, Ramirez, and Foschini are employees of Evidation Health Inc, developer of the Achievement health and research platform. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>13</Day><Hour>14</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35552722</ArticleId><ArticleId IdType="pmc">PMC9099426</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.11958</ArticleId><ArticleId IdType="pii">2792216</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . WHO coronavirus (COVID-19) dashboard. Accessed February 1, 2022. https://covid19.who.int/</Citation></Reference><Reference><Citation>Kochanek KD, Xu JQ, Arias E. Mortality in the United States, 2019.NCHS Data Brief. 2020;(395):1-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">33395387</ArticleId></ArticleIdList></Reference><Reference><Citation>Garten R, Blanton L, Elal AIA, et al. . Update: influenza activity in the United States during the 2017-18 season and composition of the 2018-19 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2018;67(22):634-642. doi:10.15585/mmwr.mm6722a4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6722a4</ArticleId><ArticleId IdType="pmc">PMC5991814</ArticleId><ArticleId IdType="pubmed">29879098</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai Y, Zhou F, Kim IK. The burden of influenza-like illness in the US workforce. Occup Med (Lond). 2014;64(5):341-347. doi:10.1093/occmed/kqu022</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqu022</ArticleId><ArticleId IdType="pmc">PMC5776017</ArticleId><ArticleId IdType="pubmed">24659109</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilcke J, Coenen S, Beutels P. Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at all. PLoS One. 2014;9(7):e102634. doi:10.1371/journal.pone.0102634</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0102634</ArticleId><ArticleId IdType="pmc">PMC4102549</ArticleId><ArticleId IdType="pubmed">25032688</ArticleId></ArticleIdList></Reference><Reference><Citation>Houts CR, Patrick-Lake B, Clay I, Wirth RJ. The path forward for digital measures: suppressing the desire to compare apples and pineapples. Digit Biomark. 2020;4(suppl 1):3-12. doi:10.1159/000511586</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000511586</ArticleId><ArticleId IdType="pmc">PMC7768118</ArticleId><ArticleId IdType="pubmed">33442577</ArticleId></ArticleIdList></Reference><Reference><Citation>Konty KJ, Bradshaw B, Ramirez E, Lee WN, Signorini A, Foschini L. Influenza surveillance using wearable mobile health devices. Online J Public Health Inform. 2019;11(1):e249. doi:10.5210/ojphi.v11i1.9758</Citation><ArticleIdList><ArticleId IdType="doi">10.5210/ojphi.v11i1.9758</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro A, Marinsek N, Clay I, et al. . Characterizing COVID-19 and influenza illnesses in the real world via person-generated health data. Patterns (N Y). 2020;2(1):100188. doi:10.1016/j.patter.2020.100188</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.patter.2020.100188</ArticleId><ArticleId IdType="pmc">PMC7815963</ArticleId><ArticleId IdType="pubmed">33506230</ArticleId></ArticleIdList></Reference><Reference><Citation>Radin JM, Wineinger NE, Topol EJ, Steinhubl SR. Harnessing wearable device data to improve state-level real-time surveillance of influenza-like illness in the USA: a population-based study. Lancet Digit Health. 2020;2(2):e85-e93. doi:10.1016/S2589-7500(19)30222-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(19)30222-5</ArticleId><ArticleId IdType="pmc">PMC8048388</ArticleId><ArticleId IdType="pubmed">33334565</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter J, Kainkaryam R, Drysdale E, et al. . Using wearables for influenza-like illness detection: the importance of design. Presented at: Machine Learning for Mobile Health Workshop, 33rd Annual Conference on Neural Information Processing System (NeurIPS 2020); December 12, 2020; Vancouver, British Columbia, Canada.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention . Estimated flu-related illnesses, medical visits, hospitalizations, and deaths in the United States&#x2014;2018-2019 flu season. Accessed October 5, 2021. https://www.cdc.gov/flu/about/burden/2018-2019.html</Citation></Reference><Reference><Citation>Evidation Health Inc.  Evidation. Accessed October 5, 2021. https://my.evidation.com/</Citation></Reference><Reference><Citation>Deering S, Grade MM, Uppal JK, et al. . Accelerating research with technology: rapid recruitment for a large-scale web-based sleep study. JMIR Res Protoc. 2019;8(1):e10974. doi:10.2196/10974</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/10974</ArticleId><ArticleId IdType="pmc">PMC6360390</ArticleId><ArticleId IdType="pubmed">30664491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Tran J, Lee WN, Bradshaw B, Foschini L, Juusola J. Longitudinal data from activity trackers show that those with greater inconsistency in activity levels are more likely to develop more severe depression. Value Health. 2018;21:S191. doi:10.1016/j.jval.2018.04.1282</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2018.04.1282</ArticleId></ArticleIdList></Reference><Reference><Citation>Budd A, Blanton L, Grohskopf L, et al. . Influenza. In: Roush SW, Baldy LM, Kirkconnell-Hall MA, eds. Manual for the Surveillance of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases; 2017.</Citation></Reference><Reference><Citation>Wasserstein RL, Schirm AL, Lazar NA. Moving to a world beyond &#x201c;p &lt; 0.05&#x201d;. Am Stat. 2019;73:S1-S19. doi:10.1080/00031305.2019.1583913</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00031305.2019.1583913</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasserstein RL, Lazar NA. The ASA&#x2019;s statement on P values: context, process, and purpose. Am Stat. 2016;70:129-133. doi:10.1080/00031305.2016.1154108</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00031305.2016.1154108</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates D, M&#xe4;chler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67:1-48. doi:10.18637/jss.v067.i01</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v067.i01</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart EA, Lee BK, Leacy FP. Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. J Clin Epidemiol. 2013;66(8)(suppl):S84-S90, 90.e1. doi:10.1016/j.jclinepi.2013.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2013.01.013</ArticleId><ArticleId IdType="pmc">PMC3713509</ArticleId><ArticleId IdType="pubmed">23849158</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J, Sweetman A. Estimating the causal effects of policies and programs. Can J Econ. 2016;49:871-905. doi:10.1111/caje.12217</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/caje.12217</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezlini AM, Das S, Goldenberg A. Finding associations in a heterogeneous setting: statistical test for aberration enrichment. bioRxiv. Preprint posted online March 25, 2020. doi:10.1101/2020.03.23.002972</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.23.002972</ArticleId><ArticleId IdType="pmc">PMC8066476</ArticleId><ArticleId IdType="pubmed">33892787</ArticleId></ArticleIdList></Reference><Reference><Citation>United States Census Bureau . Educational attainment in the United States: 2019: table 1. educational attainment of the population 18 years and over, by age, sex, race, and Hispanic origin: 2019. March 30, 2020. Accessed October 5, 2021. https://www.census.gov/content/census/en/data/tables/2019/demo/educational-attainment/cps-detailed-tables.html</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>